comparemela.com

Latest Breaking News On - Medical pharmaceuticals - Page 2 : comparemela.com

Sentynl Therapeutics Announces Global Acquisition of Zokinvy® (Lonafarnib) for Treatment of Hutchinson-Gilford Progeria Syndrome from Eiger BioPharmaceuticals

/PRNewswire/ Sentynl Therapeutics, Inc. (Sentynl), a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences, Ltd. (Zydus Group), and Eiger.

United-states
Texas
India
Japan
Ahmedabad
Gujarat
Boston
Massachusetts
United-kingdom
Great-britain
Francis-collins
Zydus-lifesciences

Vesica Health Announces Launch of AssureMDx Test to Improve Bladder Cancer Detection

New Kanguru Defender Internal Self-Encrypting Hardware-Based SSDs Provide Optimum Data Security and Performance For Laptops and Tablets

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.